333 related articles for article (PubMed ID: 16738328)
1. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.
Malecki MJ; Sanchez-Irizarry C; Mitchell JL; Histen G; Xu ML; Aster JC; Blacklow SC
Mol Cell Biol; 2006 Jun; 26(12):4642-51. PubMed ID: 16738328
[TBL] [Abstract][Full Text] [Related]
2. Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2.
Gordon WR; Vardar-Ulu D; L'Heureux S; Ashworth T; Malecki MJ; Sanchez-Irizarry C; McArthur DG; Histen G; Mitchell JL; Aster JC; Blacklow SC
PLoS One; 2009 Aug; 4(8):e6613. PubMed ID: 19701457
[TBL] [Abstract][Full Text] [Related]
3. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL.
Sulis ML; Williams O; Palomero T; Tosello V; Pallikuppam S; Real PJ; Barnes K; Zuurbier L; Meijerink JP; Ferrando AA
Blood; 2008 Aug; 112(3):733-40. PubMed ID: 18411416
[TBL] [Abstract][Full Text] [Related]
4. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Weng AP; Ferrando AA; Lee W; Morris JP; Silverman LB; Sanchez-Irizarry C; Blacklow SC; Look AT; Aster JC
Science; 2004 Oct; 306(5694):269-71. PubMed ID: 15472075
[TBL] [Abstract][Full Text] [Related]
5. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
6. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL.
Gordon WR; Roy M; Vardar-Ulu D; Garfinkel M; Mansour MR; Aster JC; Blacklow SC
Blood; 2009 Apr; 113(18):4381-90. PubMed ID: 19075186
[TBL] [Abstract][Full Text] [Related]
7. Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation.
Miyamoto A; Lau R; Hein PW; Shipley JM; Weinmaster G
J Biol Chem; 2006 Apr; 281(15):10089-97. PubMed ID: 16492672
[TBL] [Abstract][Full Text] [Related]
8. Notch1 is a frequent mutational target in chemically induced lymphoma in mouse.
Karlsson A; Ungerbäck J; Rasmussen A; French JE; Söderkvist P
Int J Cancer; 2008 Dec; 123(11):2720-4. PubMed ID: 18798262
[TBL] [Abstract][Full Text] [Related]
9. Evidence for increased exposure of the Notch1 metalloprotease cleavage site upon conversion to an activated conformation.
Tiyanont K; Wales TE; Aste-Amezaga M; Aster JC; Engen JR; Blacklow SC
Structure; 2011 Apr; 19(4):546-54. PubMed ID: 21481777
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.
Aste-Amézaga M; Zhang N; Lineberger JE; Arnold BA; Toner TJ; Gu M; Huang L; Vitelli S; Vo KT; Haytko P; Zhao JZ; Baleydier F; L'Heureux S; Wang H; Gordon WR; Thoryk E; Andrawes MB; Tiyanont K; Stegmaier K; Roti G; Ross KN; Franlin LL; Wang H; Wang F; Chastain M; Bett AJ; Audoly LP; Aster JC; Blacklow SC; Huber HE
PLoS One; 2010 Feb; 5(2):e9094. PubMed ID: 20161710
[TBL] [Abstract][Full Text] [Related]
11. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ
Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600
[TBL] [Abstract][Full Text] [Related]
12. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats.
Sanchez-Irizarry C; Carpenter AC; Weng AP; Pear WS; Aster JC; Blacklow SC
Mol Cell Biol; 2004 Nov; 24(21):9265-73. PubMed ID: 15485896
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
[TBL] [Abstract][Full Text] [Related]
14. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.
Aster JC
Int J Hematol; 2005 Nov; 82(4):295-301. PubMed ID: 16298817
[TBL] [Abstract][Full Text] [Related]
15. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
Pancewicz J; Taylor JM; Datta A; Baydoun HH; Waldmann TA; Hermine O; Nicot C
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16619-24. PubMed ID: 20823234
[TBL] [Abstract][Full Text] [Related]
16. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
17. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
18. Force-induced unfolding simulations of the human Notch1 negative regulatory region: possible roles of the heterodimerization domain in mechanosensing.
Chen J; Zolkiewska A
PLoS One; 2011; 6(7):e22837. PubMed ID: 21829530
[TBL] [Abstract][Full Text] [Related]
19. Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1.
Chiang MY; Xu ML; Histen G; Shestova O; Roy M; Nam Y; Blacklow SC; Sacks DB; Pear WS; Aster JC
Mol Cell Biol; 2006 Aug; 26(16):6261-71. PubMed ID: 16880534
[TBL] [Abstract][Full Text] [Related]
20. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.
Rodig SJ; Payne EG; Degar BA; Rollins B; Feldman AL; Jaffe ES; Androkites A; Silverman LB; Longtine JA; Kutok JL; Fleming MD; Aster JC
Am J Hematol; 2008 Feb; 83(2):116-21. PubMed ID: 17874453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]